SK282537B6 - Inhibítor tryptázy alebo jeho farmaceuticky prijateľná soľ, farmaceutický prostriedok s jeho obsahom a jeho použitie - Google Patents
Inhibítor tryptázy alebo jeho farmaceuticky prijateľná soľ, farmaceutický prostriedok s jeho obsahom a jeho použitie Download PDFInfo
- Publication number
- SK282537B6 SK282537B6 SK1129-95A SK112995A SK282537B6 SK 282537 B6 SK282537 B6 SK 282537B6 SK 112995 A SK112995 A SK 112995A SK 282537 B6 SK282537 B6 SK 282537B6
- Authority
- SK
- Slovakia
- Prior art keywords
- hydrogen
- substituted
- hydroxy
- pharmaceutically acceptable
- tryptase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
- C07K5/06095—Arg-amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3077093A | 1993-03-12 | 1993-03-12 | |
US3118793A | 1993-03-12 | 1993-03-12 | |
PCT/US1994/002706 WO1994020527A1 (en) | 1993-03-12 | 1994-03-11 | Compositions and methods for the treatment of immunomediated inflammatory disorders |
Publications (2)
Publication Number | Publication Date |
---|---|
SK112995A3 SK112995A3 (en) | 1996-10-02 |
SK282537B6 true SK282537B6 (sk) | 2002-10-08 |
Family
ID=26706445
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1129-95A SK282537B6 (sk) | 1993-03-12 | 1994-03-11 | Inhibítor tryptázy alebo jeho farmaceuticky prijateľná soľ, farmaceutický prostriedok s jeho obsahom a jeho použitie |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP0688337A1 (ja) |
JP (1) | JPH08507768A (ja) |
KR (1) | KR100309616B1 (ja) |
CN (2) | CN1057772C (ja) |
AU (1) | AU683459B2 (ja) |
CZ (1) | CZ289930B6 (ja) |
FI (1) | FI954245A (ja) |
PL (1) | PL176941B1 (ja) |
SK (1) | SK282537B6 (ja) |
UA (1) | UA42719C2 (ja) |
WO (1) | WO1994020527A1 (ja) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH10501238A (ja) * | 1994-06-01 | 1998-02-03 | アリス ファーマシューティカル コーポレイション | 肥満細胞媒介症状を治療するための組成物及び方法 |
EP0782571A1 (en) * | 1994-09-23 | 1997-07-09 | Arris Pharmaceutical Corporation | Compositions and methods for treating mast-cell inflammatory condition |
WO1997037969A1 (fr) | 1996-04-10 | 1997-10-16 | Ono Pharmaceutical Co., Ltd. | Inhibiteur de tryptase derives de guanidino |
KR20000029679A (ko) * | 1996-07-30 | 2000-05-25 | 헤이즈 더블유.그쉬웬드 다니엘 에이치.페트리 | 트립타아제활성관련질병을치료하기위한화합물및조성물 |
US5968782A (en) * | 1996-12-04 | 1999-10-19 | Brigham And Womens's Hospital, Inc. | Mast cell protease that cleaves fibrinogen |
WO1998033812A1 (en) * | 1997-02-05 | 1998-08-06 | Brigham And Women's Hospital, Inc. | Mast cell protease peptide inhibitors |
US6221914B1 (en) | 1997-11-10 | 2001-04-24 | Array Biopharma Inc. | Sulfonamide bridging compounds that inhibit tryptase activity |
AU1208999A (en) * | 1997-11-10 | 1999-05-31 | Array Biopharma, Inc. | Compounds which inhibit tryptase activity |
WO1999026925A1 (fr) * | 1997-11-26 | 1999-06-03 | Yoshitomi Pharmaceutical Industries, Ltd. | Inhibiteurs de tryptase comprenant des composants d'amide heterocycliques |
SE515982C2 (sv) * | 1998-03-06 | 2001-11-05 | Lipocore Holding Ab | Användning av en olja-i-vatten emulsion som bärare för framställning av en topikal kräm eller lotion |
SE9800729L (sv) * | 1998-03-06 | 1999-09-07 | Scotia Lipidteknik Ab | Ny topikal formulering I |
DE19939910A1 (de) * | 1999-08-23 | 2001-03-01 | Morphochem Ag | Neue Verbindungen, die Tryptase-Aktivität hemmen |
GB0507577D0 (en) * | 2005-04-14 | 2005-05-18 | Novartis Ag | Organic compounds |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4201863A (en) * | 1974-11-08 | 1980-05-06 | Mitsubishi Chemical Industries, Limited | N2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof |
US4456595A (en) * | 1982-12-06 | 1984-06-26 | E. R. Squibb & Sons, Inc. | Carboxy and substituted carboxy aroly peptides |
-
1994
- 1994-03-11 UA UA95104466A patent/UA42719C2/uk unknown
- 1994-03-11 KR KR1019950703932A patent/KR100309616B1/ko not_active IP Right Cessation
- 1994-03-11 WO PCT/US1994/002706 patent/WO1994020527A1/en not_active Application Discontinuation
- 1994-03-11 EP EP94910926A patent/EP0688337A1/en not_active Ceased
- 1994-03-11 AU AU63647/94A patent/AU683459B2/en not_active Ceased
- 1994-03-11 JP JP6520352A patent/JPH08507768A/ja not_active Ceased
- 1994-03-11 PL PL94310559A patent/PL176941B1/pl unknown
- 1994-03-11 SK SK1129-95A patent/SK282537B6/sk unknown
- 1994-03-11 CZ CZ19952321A patent/CZ289930B6/cs not_active IP Right Cessation
- 1994-03-11 CN CN94191441A patent/CN1057772C/zh not_active Expired - Fee Related
-
1995
- 1995-09-11 FI FI954245A patent/FI954245A/fi unknown
-
1998
- 1998-06-15 CN CN98102273A patent/CN1234229A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
CZ232195A3 (en) | 1996-07-17 |
PL176941B1 (pl) | 1999-08-31 |
AU683459B2 (en) | 1997-11-13 |
CN1057772C (zh) | 2000-10-25 |
KR100309616B1 (ko) | 2002-02-28 |
SK112995A3 (en) | 1996-10-02 |
FI954245A0 (fi) | 1995-09-11 |
UA42719C2 (uk) | 2001-11-15 |
WO1994020527A1 (en) | 1994-09-15 |
CN1234229A (zh) | 1999-11-10 |
AU6364794A (en) | 1994-09-26 |
CN1119019A (zh) | 1996-03-20 |
CZ289930B6 (cs) | 2002-04-17 |
EP0688337A1 (en) | 1995-12-27 |
JPH08507768A (ja) | 1996-08-20 |
PL310559A1 (en) | 1995-12-27 |
FI954245A (fi) | 1995-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5525623A (en) | Compositions and methods for the treatment of immunomediated inflammatory disorders | |
US6211228B1 (en) | Compositions and methods for treating mast-cell mediated conditions | |
SK282537B6 (sk) | Inhibítor tryptázy alebo jeho farmaceuticky prijateľná soľ, farmaceutický prostriedok s jeho obsahom a jeho použitie | |
US5656660A (en) | Compositions and methods for treating mast-cell mediated conditions | |
SA94140584B1 (ar) | اريل لسلفون اميدو- هيدروكساميك مستبدلة | |
JP2003506491A (ja) | 細胞接着インヒビター | |
HU226979B1 (en) | Bicyclic lactam inhibitor of interleukin-1-beta converting enzyme and pharmaceutical compositions containing them | |
JP2002516309A (ja) | 新規VLA−4阻害剤:oMePUPA−V | |
US9199917B2 (en) | N-substituted benzenepropanamide or benzenepropenamide derivatives for use in the treatment of pain and inflammation | |
JPH10502656A (ja) | ヒトs−cd23の阻害剤の使用 | |
WO1996041631A1 (en) | Methods of treating cold and allergic rhinitis | |
US6673965B1 (en) | Hydroxamic acid derivative as inhibitor of the formation of soluble human CD23 | |
EP1101492A1 (en) | Novel remedies for allergic diseases | |
JPH0426631A (ja) | 血管新生抑制剤 | |
Duflos et al. | 6-Amino-2, 4-lutidine carboxamides: α-aminoamide derivatives as systemic and topical inflammation inhibitors | |
US20020082200A1 (en) | Use of inhibitors of human S-CD23 | |
WO1997025981A1 (en) | Medical use | |
MXPA01000563A (en) | Novel remedies for allergic diseases | |
MXPA00007186A (en) | Vla-4 antagonists |